NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Patients with head and neck squamous cell carcinoma diagnosed with recurrent tumor or distant metastases usually have the worst prognosis. Chemotherapeutic options are very limited in these patients; there is a probability of drug resistance development. The researchers continue to search more effec...

Full description

Bibliographic Details
Main Authors: A. M. Mudunov, M. N. Narimanov, D. A. Safarov
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Opuholi Golovy i Šei
Subjects:
head and neck tumors
squamous cell carcinoma
pd-1
immune therapy
nivolumab
pembrolizumab
Online Access:https://ogsh.abvpress.ru/jour/article/view/271

Internet

https://ogsh.abvpress.ru/jour/article/view/271

Similar Items